Best Life Sciences Companies in Lower Saxony, Germany
The 74 best Life Sciences companies in Lower Saxony, Germany in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Cardior Pharmaceuticals.
Our analysis of 50 Life Sciences companies
$3.3b in tracked funding; 51% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2024.
Ranked: Best Life Sciences companies in Lower Saxony
| # | Company | Disclosed funding | Last round | Employees | Founder | Stage | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | 42 life sciences Developer of reagents for research applications | — | — | 19 | Bastian Eirich Managing Director | Funding Raised | 180 patents Patents concentrated in chemistry & materials | — |
| 2 | Accurion Provider of surface analysis tools for nanosized characterization | — | — | 35 | Marcus Liemen Managing Director | Acquired | 10 patents Precise optical ellipsometry and polarization analysis for thin‑film/material property characterization. | — |
| 3 | AdnaGen Genetic diagnostic testing systems for the medical and clinical research laboratories | — | — | — | Wolfram Rodatz CEO | Acqui-Hired | 68 patents Liquid biopsy platforms for isolating/enriching targets and molecular diagnostics of cells. | — |
| 4 | AELVIS Offers products and services in protein analysis | — | — | — | Heinfried Radeke Founder & CEO | Unfunded | — | — |
| 5 | AMD Analysis & Technology Provider of a range of magnetic sector mass spectrometers | — | — | — | Karl Heinz Maurer CEO & President | Deadpooled | — | — |
| 6 | AMD Analysis and Technology Developer of magnetic sector mass spectrometers | — | — | — | Karl-Heinz Maurer CEO | Deadpooled | — | — |
| 7 | AMODIA Bioservice Developer and manufacturer of diagnostic products | — | — | — | Ulrich Krause Founder & Managing Director | Unfunded | 4 patents Microfluidic cartridges for immunological and molecular diagnostic analysis machines | — |
| 8 | BacDive Online database providing information about bacterial and archaeal biodiversity | — | — | — | Jorg Overmann Founder | Unfunded | — | — |
Top 12 Life Sciences companies in Lower Saxony
#1
Seed · Hanover, Lower Saxony · founded 2001$3.8Mraised▾
Developer of therapeutics to prevent transplant rejection. It offers therapeutics that treats the transplant instead of paralyzing the patient's immune system for better graft survival by reducing the immunogenicity of donor organs.
- Aug 2024Seed$3.8M
#2
Acquired · Hannover, Lower Saxony · founded 2016 · 34 employees$92.3Mraised▾
Developer of non-coding RNA-based therapeutics to treat cardiovascular diseases. The company uses oligonucleotide-based inhibitors to target molecular targets such as non-coding RNAs which have been linked to heart failure development that simultaneously control cardiac growth and calcium handling and contractility of cardiomyocytes.
- Aug 2021Series B$76M
- Jan 2019Grant (prize money)$1M
- May 2017Series A$16.3M
#3
Funding Raised · Wolfenbuttel, Lower Saxony · founded 1991$2Mraised▾
ASA Spezialenzyme is engaged in the development and manufacture of enzymes, microbial mixed cultures, and other biotech products to support industries such as food processing, fine chemicals, biosensors, textiles, paper, and biogas. The company also offers research services including conceptualization and implementation of R&D projects, and technical support and consultation for activities such as bioremediation of water bodies, water analysis, soil bioremediation, and restoration of heavy metal contaminated soils.
- Apr 2023Grant (prize money)$236.7K
- Aug 2020Grant (prize money)$456.7K
- Jun 2019Grant (prize money)$1.1M
- Nov 2018Grant (prize money)$199.4K
#4
Acquired · Gottingen, Lower Saxony · founded 1996$74.6Mraised▾
Discovery of novel therapeutics for the treatment of metabolic and endocrine disorders
#5
Series C · Hannover, Lower Saxony · founded 2009 · 9 employees$8.5Mraised▾
Implandata Ophthalmic Products GmbH (IOP) is a medical device company. IOP has developed a technology for 24 hour measurement of intraocular pressure, for monitoring and treatment of glaucoma patients. The Eyemate system consists of an implantable, biocompatible microsensor for the telemetric measurement of intraocular pressure,
- May 2018Series C—
- Jan 2016Grant (prize money)$270.6K
- Oct 2014Series B$3.8M
- Aug 2012Series A$2M
#6
Funding Raised · Hannover, Lower Saxony · founded 2002$3.4Mraised▾
Mosaiques Diagnostics has developed proteome-based diagnostics derived from their data collected from over 5000 patient samples using a CE-ToF MS platform. The company claims that this data has yielded a collection of around 2500 biomarkers which forms the basis of their relational database in the context of genitourinary, cardiovascular, oncological and dementia related diseases. The company currently has urine based non-invasive tests for bladder cancer staging, prostate cancer, cholangiocarcinoma, GvHD after allo-HSCT, chronic kidney disease, diabetic nephropathy, coronary artery disease, myocardial infarction, and heart failure derived from their proteomic biomarker collection, with more tests in development.
- Jun 2020Grant (prize money)$181.1K
- Feb 2020Grant (prize money)$280.5K
- Jan 2020Grant (prize money)$786.5K
- Aug 2018Grant (prize money)$200K
#7
Deadpooled · Hannover, Lower Saxony · founded 2008 · 4 employees$4.7Mraised▾
Provider of drug delivery platform for the treatment of bacterial infections and viral diseases. Offers proprietary TargoSphere technology, a nanocarrier platform to achieve enhanced prophylactic and therapeutic approaches against diseases. Claims that TargoSphere can carry high concentrations of compounds spanning a broad range of sizes and structures of classical small molecule drugs to biomolecules, such as proteins, peptides, and nucleic acids. Currently applies TargoSphere technology for two in-house therapeutic applications Targobiotics, for intracellular treatment of bacterial infections, and Targovir, for the treatment of viral diseases.
- Aug 2017Series A$940.7K
- 2016Series A$368.9K
- Apr 2013Series A$3.4M
#8
Funding Raised · Braunschweig, Lower Saxony · founded 2008 · 9 employees$358Kraised▾
InScreenEx develops and produces customized cell lines for in vitro screening assays. The company's screenflex program provides customized stable cell lines for assay development, while CI-screen maintains a database of immortalized cell lines and provides off-the-shelf cell immortalization. The company also provides optimized cell culture media and reagents, as well as cell culture services.
- Feb 2022Grant (prize money)$11.5K
- Jun 2019Grant (prize money)$56K
- Jan 2019Grant (prize money)$56K
- Mar 2017Grant (prize money)$117.2K
#9
Funding Raised · Saterland, Lower Saxony · founded 2017 · 9 employees$1.3Mraised▾
Provider of workflow management tools for drug research and discovery. It enables pharmaceutical industries and research industries to manage their data for research and development.
- May 2021Grant (prize money)$1.3M
#10
Funding Raised · Wolfenbuttel, Lower Saxony · founded 2010$1Mraised▾
Provider of bioinformatics and systems biology software. Products include eneXplain platform which is an online toolbox and workflow management system, GenomeTraveler- whole-genome analysis software, In-silico Molecular Cloning (IMC) software for analysis, annotation, and visualization of genomic features, PASS- Prediction of Activity Spectra for Substances, PharmaExpert which for study relationships between biological activities, drug-drug interactions and multiple targeting of chemical compounds, GUSAR which is a tool for quantitative structure-activity relationships and BRENDA which is a database of enzymes and enzyme-ligand data. It also is a part of active research.
- Jan 2018Grant (prize money)$341.7K
- Jan 2017Grant (prize money)$263.9K
- Jan 2017Grant (prize money)$406.4K
#11
Funding Raised · Friesoythe, Lower Saxony · founded 2004$1Mraised▾
Developer of immunological and cell biological reagents. The company specializes in the development and manufacturing of high-quality antibodies and recombinant cytokines for research purposes. The company offers a wide range of products, including antibodies against human and murine antigens, and cytokines such as rh CNTF and rh MCP-1.
- Apr 2015Grant (prize money)$373.4K
- Jan 2015Grant (prize money)$645.6K
#12
Seed · Hannover, Lower Saxony · founded 2008 · 49 employees$247.8Kraised▾
Syntellix is developing the bioabsorbable metallic implants for joint reconstruction. Its products include cs screws MAGNEZIX CS that help in the fixation of bone or bone fragments, MAGNEZIX CBS is an antiinfective device that promotes bone formation.
- Oct 2018Grant (prize money)$247.8K
- Jul 2018Seed—
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology is moving in Germany
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 1,297 Germany-affiliated papers.
- Heidelberg University85
- German Cancer Research Center49
- Ludwig-Maximilians-Universität München48
- Technical University of Munich43
- Karlsruhe Institute of Technology33
- Gene3→29
- Mutant3→19
- Transcription (linguistics)3→16
- Messenger RNA1→14
- Immune system1→12
- Gene3→20
- Agriculture2→12
- Extracellular1→11
- Immune system1→11
- Transcriptome1→9
- Antibiotic resistance2→9
- Gene1→7
- Agriculture4→9
- Antimicrobial1→4
- Microbiome1→4
Where biotechnology is researched across Germany
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Who's filing biotechnology patents in Germany
Germany biotechnology patent filing is cooling — 53,233 filings from 8,000 assignees (2016–2025), led by Immatics Biotechnologies, BASF Plant Science, BASF SE; annual filings 4819→4267.
- Immatics Biotechnologies4872
- BASF Plant Science3982
- BASF SE3543
- Boehringer Ingelheim INT3438
- Merck Patent3133
- MAX Planck Gesellschaft1799
- Evonik Degussa1680
- Amgen RES Munich1665
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.